Tenax Therapeutics (TENX) Profit After Tax (2010 - 2026)

Tenax Therapeutics (TENX) has 17 years of Profit After Tax data on file, last reported at -$15.7 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 51.0% year-over-year to -$15.7 million; the trailing twelve-month figure through Mar 2026 stood at -$57.9 million (down 139.03% YoY), and the FY2025 full-year result was -$52.6 million, down 198.86% from the prior year.
• Profit After Tax retreated to -$15.7 million in Q1 2026, from -$15.5 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $2.9 million in Q3 2022 to a low of -$15.8 million in Q3 2025.
• A 5-year average of -$5.8 million and a median of -$3.8 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax jumped 104.13% in 2022 and sank 578.07% in 2023, its largest moves.
• Tracing TENX's Profit After Tax over 5 years: stood at $2.5 million in 2022, then slumped by 578.07% to -$12.2 million in 2023, then surged by 48.58% to -$6.3 million in 2024, then tumbled by 147.41% to -$15.5 million in 2025, then slipped by 1.39% to -$15.7 million in 2026.
• Business Quant data shows TENX's Profit After Tax at -$15.7 million in Q1 2026, -$15.5 million in Q4 2025, and -$15.8 million in Q3 2025.